Reyglim 1 Tablet
Marketer
Sanrey Therapeutics
Salt Composition
Glimepiride (1mg)
Overview Reyglim 1 Tablet
Glimepiride (1 mg) is a sulfonylurea-class medication indicated for adult-onset type 2 diabetes management. It regulates blood glucose, mitigating serious diabetic complications like vision impairment and nephropathy. This medication can be administered alone or in conjunction with other therapies. Optimal results necessitate consistent daily dosing, ideally with or immediately before the first meal. Dosage adjustments, determined by your physician based on glucose monitoring, may be necessary. Continuous use, even with seemingly controlled blood sugar, is crucial. Premature discontinuation, without medical consultation, elevates the risk of complications including kidney failure, blindness, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan encompassing diet, physical activity, and weight management as directed by your doctor. Lifestyle choices are pivotal in diabetes control. Common adverse effects include hypoglycemia, nausea, cephalalgia, asthenia, and vertigo. Learn to identify hypoglycemic symptoms—sweating, dizziness, headache, tremor—and implement appropriate countermeasures. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are recommended. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Weight gain is a possible side effect. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior to initiating treatment, inform your physician of any history of cardiac disease, thyroid disorders, or endocrine abnormalities. Pregnant or lactating individuals should seek medical advice before use. Regular blood glucose monitoring and periodic blood tests to assess hematologic parameters and liver function are essential.
Primary Ingredients of Reyglim 1 Tablet
The provided text is "undefined," which offers no meaning to rephrase. Therefore, no rewritten text can be provided.
Uses of Reyglim 1 Tablet
Managing type 2 diabetes
Major Benefits of Reyglim 1 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. One Reyglim tablet should be taken with a meal.
Common Side effects of Reyglim 1 Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Dizziness
- Weakness
How to use Reyglim 1 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer one Reyglim tablet with a meal.
How Reyglim 1 Tablet works:
One Reyglim tablet is an antidiabetic agent that functions by stimulating pancreatic insulin secretion, thereby reducing blood sugar levels.
SAFETY ADVICE
AlcoholUNSAFE
Combining Reyglim 1 Tablet with alcohol is strongly discouraged due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Reyglim 1 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Reyglim 1 Tablet while breastfeeding is likely unsafe. Studies in humans indicate potential transfer of the medication into breast milk, posing a risk to the infant. Close monitoring of the nursing infant's blood sugar levels is recommended if the mother takes Reyglim 1 Tablet.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Caution is advised when administering a single Reyglim tablet to individuals with kidney impairment; dosage modification may be necessary. Physician consultation is recommended. Reyglim single-tablet administration is contraindicated in patients with severe kidney disease due to the risk of profound hypoglycemia, which may resolve gradually.
LiverCAUTION
Patients with liver impairment should use Reyglim 1 Tablet cautiously, potentially requiring dose modification. Consult a physician. Reyglim 1 Tablet is contraindicated in patients with severe hepatic dysfunction due to the risk of severe hypoglycemia, which may resolve gradually.
What if you forget to take Reyglim 1 Tablet :
Omit the forgotten Reyglim 1 Tablet dose; resume your regular dosing schedule with the next scheduled tablet.
Facts to Know About Reyglim 1 Tablet
| Label | Value |
|---|---|
| Chemical Category | Advanced Sulfonylurea |
| Developing Habits | No. |
| Type of Treatment | Diabetes Management |




